Jonas Anderson, American University Washington College of Law, with a panel consisting of Jennifer Thomas of Hyman, Phelps & McNamara, PC, representing Pharmaceutical Care Management Association, et al. on amicus brief; Donald Ware of Foley Hoag... [read post]

  The case, In Re Valsartan, Losartan, and Irbesartan Products Liability Litigation (US DC NJ) MDL No. 2875 (RBK)is a products liability case that concerns the sale in the U.S. of generic, prescription Valsartan pharmaceuticals, found by the Food and Drug Administration [“FDA”] to contain cancer‐causing contaminants. [read post]